Metall Zug AG Class B · SIX:METN
Metall Zug AG Class B — H1 2018 Earnings Presentation
43 slides from Metall Zug AG Class B's earnings presentation, Aug 20, 2018
Slide 1: Investor Presentation HY 1/18
Investor Presentation HY 1/18 Metall Zug Group, August 20, 2018 1
Slide 2: Content
Metall Zug Group Content 1. Metall Zug Group - Overview HY 1/18 2. Business Units Household Appliances Infection Control Wire Processing Medical Devices 3. Group Financial Report HY 1/18 4. Technology Cluster Zug 5. Information for Investors Investor Presentation HY 1/18 2
Slide 3: Metall Zug Group – Overview HY 1/18
Metall Zug Group – Overview HY 1/18
Slide 4: Metall Zug Group Overview HY 1/18
Metall Zug Group Overview HY 1/18 – Group gross sales of CHF 554.2 million, significant growth of +24.4% (previous year: CHF 445.4 million), pleasing organic sales growth of 4.9%: Household Appliances with higher sales in Switzerland and solid growth in most international markets, especially in the
Slide 5: Business Units
NG _ az METALL ZUG Business Units
Slide 6: Household Appliances
Household Appliances HY 1/18: Net sales MCHF 286.5, EBIT MCHF 21.7 Tanja Grandits, long-standing V-ZUG Ambassador, Restaurant Stucki in Basel (Switzerland) Investor Presentation HY 1/18 6
Slide 7: Household Appliances – Key figures and overview
Household Appliances Key figures and overview CHF million HY 1/18 HY 1/17 ∆ 2017 Net sales to third parties 286.5 269.4 6.3 % 572.9 Operating income (EBIT) 21.7 26.5 -18.2 % 65.4 EBIT margin in % 7.6 9.8 -227 bp 11.4 – Pleasing organic gross sales growth of 6.4% (acquisition effect: 0.0%; FX effect:
Slide 8: Household Appliances – International markets
Household Appliances International markets CHF million HY 1/18 HY 1/17 2017 2016 2015 2014 2013 Net sales to third parties (international) 21.6 11.7 44.3 46.7 36.0 35.1 24.6 in % of total Business Unit net sales 7.5% 4.3% 7.7% 8.0% 6.3% 6.1% 4.4% - Europe (excluding Switzerland) 7.6 6.0 14.1 11.4 11
Slide 9: Production site in Zug & V-ZUG Innovation Lab
Household Appliances Production site in Zug & V-ZUG Innovation Lab Development plan – Approval of the development plan by the Parliament of the City of Zug (Grosser Gemeinderat) – Development plan to be finally approved by the Cantonal Government (Regierungsrat) as a basis for the overall transforma
Slide 10: Household Appliances – Strategic priorities
Household Appliances Strategic priorities – Strengthen the market leadership of V-ZUG in Switzerland and its premium brand worldwide as a leader in innovation, technology and quality with Swiss-made products – Expand and strengthen the international business in the premium segment in selected countr
Slide 11: Infection Control
Infection Control HY 1/18: Net sales MCHF 85.2; EBIT MCHF –8.3 Shkodran Qerimi, deputy head of the Central Sterile Supply Department (CSSD) of the Schulthess Clinic in Zurich (Switzerland) Investor Presentation HY 1/18 11
Slide 12: Infection Control – Key figures and overview
Infection Control Key figures and overview CHF million HY 1/18 HY 1/17 ∆ 2017 Net sales to third parties 85.2 85.6 -0.4 % 188.1 Operating income (EBIT) -8.3 -10.1 17.3% -34.2 EBIT margin in % -9.8 -11.8 200 bp -18.2 – Gross sales: organic decline of 2.0% (acquisition effect: +0.1%; FX effect: +1.9%)
Slide 13: Belimed Life Science separation
Infection Control Belimed Life Science Strategic decision to separate the Life Science business into a new Business Unit, independent from Belimed AG (communicated on June 5, 2018) Provisions and impairments charged to the 2017 P&L: Provisions of CHF 13.1 million for restructuring, and impairmen
Slide 14: Belimed Life Science – higher focus and reduced complexity
Infection Control Belimed Life Science – higher focus and reduced complexity Higher focus / reduced complexity Lean product portfolio: 3 washers/disinfectors (previously: 5), 4 clean stations (6), 2 steam sterilizers (4) Selective order intake: Focus on core markets and sufficient margin of proj
Slide 15: Infection Control – Strategic priorities
Infection Control Strategic priorities Secure benefits from reduced complexity of the business structure and processes in the Medical & Service Business Area as a pure player; therefore… Establish Belimed Life Science’s new structure and prepare for future profitable growth Increase market sha
Slide 16: Wire Processing
Wire Processing HY 1/18: Net sales MCHF 98.0, EBIT MCHF 11.8 Andreas Engels, Head of IT Europe at YAZAKI in Cologne (Germany) Investor Presentation HY 1/18 16
Slide 17: Wire Processing – Key figures and overview
Wire Processing Key figures and overview CHF million HY 1/18 HY 1/17 ∆ 2017 Net sales to third parties 98.0 81.9 19.7 % 175.7 Operating income (EBIT) 11.8 11.1 6.2 % 22.3 EBIT margin in % 12.0 13.5 -152 bp 12.7 – Organic gross sales growth of 6.9% (acquisition effect: +12.4%; FX effect: +1.9%) (Prev
Slide 18: Acquisition of 60% of Adaptronic Prüftechnik GmbH
Wire Processing Acquisition of 60% of Adaptronic Prüftechnik GmbH – Schleuniger acquired 60% of Adaptronic (completion: January 4, 2018), a leader in wire test systems and function test systems, employing around 140 people and generating sales of about EUR 14 million in 2016 – Adaptronic (focused on
Slide 19: Wire Processing – Strategic priorities
Wire Processing Strategic priorities Continuing transformation of Schleuniger from a high-quality machine manufacturer and solution provider into a strategic system partner for its customers Expand the product range for the automotive industry and in the automotive value chain, including IT-enab
Slide 20: Medical Devices
Medical Devices HY 1/18 (4 months, March-June): Net sales MCHF 72.0, EBIT MCHF 10.1 David A. Goldman, M.D., owner of the Goldman Eye practice in Palm Beach Gardens, Florida (US) Investor Presentation HY 1/18 20
Slide 21: Medical Devices – Key figures and overview
Medical Devices Key figures and overview CHF million HY 1/181 HY 1/17 ∆ 2017 Net sales to third parties 72.0 NA NA NA Operating income (EBIT) 10.1 NA NA NA EBIT margin in % 14.0 NA NA NA 1) 4 months (March – June 2018) – Gross sales with pleasing development in all three Business Areas (Diagnostics,
Slide 22: Various initiatives (One Haag-Streit)
Medical Devices Various initiatives (One Haag-Streit) – Initiation of various initiatives to develop Haag-Streit, defending its strong market position and leveraging the emerging opportunities for internal and external growth – Project team comprising representatives from Haag-Streit and Metall Zug
Slide 23: Medical Devices – Strategic priorities
Medical Devices Strategic priorities Increase margins based on operational excellence including digitization of processes Secure potential from geographic expansion and increase market share in markets with below-average presence Explore benefits from digitization of products and services De
Slide 24: Group Financial Report HY 1/18
Group Financial Report HY 1/18
Slide 25: Group financial report – Key figures HY 1/18
Group financial report Key figures HY 1/18 CHF million HY 1/18 HY 1/17 ∆ 2017 – Pleasing organic gross sales growth in local currencies of 4.9% (acquisition effect of +18.8%, Gross sales 554.2 445.4 24.4 % 959.2 FX effect of +0.7%) Operating income – Operating income (EBIT) up 29% to CHF 36.4 36.4 2
Slide 26: Group financial report – Income statement
Group financial report Income statement CHF million HY 1/18 in % HY 1/17 in % Comments Acquisition effect: +18.8%; FX effect: +0.7% Gross sales 554.2 100.0% 445.4 100.0% Organic growth rate in local currencies: +4.9% Net sales 541.8 97.8% 436.9 98.1% Cost of materials (incl. ∆ inventories) -181.0 32
Slide 27: Group financial report – Gross sales analysis
Group financial report Gross sales analysis ORGANIC GROWTH1) EXTERNAL REPORTED 1) BU organic growth in % of BUs’ gross sales Investor Presentation HY 1/18 27
Slide 28: Group financial report – Operating income (EBIT) analysis
Group financial report Operating income (EBIT) analysis OPERATIONAL (BUs)1) CORPORATE REPORTED 1) BU EBIT changes in CHF millions Investor Presentation HY 1/18 28
Slide 29: Group financial report – Seasonality
Group financial report Metall Zug Group seasonality * HY 1/16 as a % of FY excl. MCHF 5.1 extraordinary profit (sale of the property in Ballwil) ** HY 1/17 as a % of FY excl. MCHF 20.8 extraordinary expenses for the restructuring of Belimed Life Science business Investor Presentation HY 1/18 29
Slide 30: Group financial report – Balance sheet
Group financial report Balance sheet CHF million 06/30/2018 in % 12/31/2017 in % Comments Cash and cash equivalents / securities 213.1 20.3 525.4 44.2 Acquisition of Haag-Streit and Adaptronic, dividend Other current assets 440.6 42.0 316.7 26.7 Higher receivables and inventories Current assets 653.
Slide 31: Group financial report – Cash flow statement
Group financial report Cash flow statement CHF million HY 1/18 HY 1/17 2017 Comments Cash flow from operating activities 240.3 -0.4 90.1 Reduction of the securities portfolios to finance acquisition of - of which change in securities 225.8 -4.4 32.4 Haag-Streit and Adaptronic Cash flow from investin
Slide 32: Technology Cluster Zug
NG —_ Zz METALL ZUG Technology Cluster Zug
Slide 33: Technology Cluster Zug – Development Plan approval
Technology Cluster Zug Approval of the Development Plan by the Parliament of the City of Zug Construction work started for Zephyr Phase I New production concepts such as the “vertical factory” employed in the strategic modernization of the V-ZUG production site to reduce the floor space required a
Slide 34: Future projects related to the Technology Cluster Zug
Technology Cluster Zug Future projects related to the Technology Cluster Zug Mobility Hub Zug Nord (MHZN) planned on the northern part of the site, with an entry gate location to the city A Multi Energy Hub to be created with partners to supply the Technology Cluster Zug with local, renewable en
Slide 35: Information for Investors
NG —_ Zz METALL ZUG Information for Investors
Slide 36: Investment case
Investment case Well positioned in attractive markets with growth potential All Business Units are well positioned in attractive markets with growth potential based on competitive product portfolios, strong customer relationships and opportunities related to digital business and processes – Earnin
Slide 37: Financial calendar
Metall Zug Group Financial calendar March 21, 2019 Publication of the 2018 results May 3, 2019 General Meeting of Shareholders Investor Presentation HY 1/18 37
Slide 38: Contact
Metall Zug Group Contact Daniel Keist Chief Financial Officer Metall Zug AG Industriestrasse 66 6302 Zug Switzerland Phone: +41 58 768 60 50 Investor Presentation HY 1/18 38
Slide 39: Appendix
NG —_ Zz METALL ZUG Appendix
Slide 40: Dividend
Dividend Payout in CHF millions and payout ratio 3 101% 86%3 1 1 1 2 4 36% 1 Special anniversary (2012) or stock (2015) dividend not included in the payout ratio 2 Payout ratio adjusted by extraordinary financial result 2013 (CHF 43 million due to sale of larger portion and revaluation of the remain
Slide 41: Dividend per share
Dividend per share Payout in CHF per type B registered share and yield (vs. year-end share price) 1 2 1 Special anniversary dividend 2 Incl. allocation of shares and withholding tax refund claim Investor Presentation HY 1/18 41
Slide 42: Shareholder structure
Shareholder structure As at December 31, 2017 Capital Votes Investor Presentation HY 1/18 42
Slide 43: Disclaimer
Metall Zug Group Disclaimer Metall Zug AG has made great efforts to include accurate and up-to-date information in this document. However, we make no representations or warranties, expressed or implied, as to the accuracy or completeness of the information provided in this document and disclaim any